liocyx
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2018 (NCT03634683)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Hepatitis B virusImmunity, passive
Hepatitis B virus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06885710 | Phase 1 | Dec 31, 2024 | Changhai Hospital |
| NCT05195294 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2022 | Lion TCR Pte. Ltd. |
| NCT03634683 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2018 | Agency for Science, Technology and Research, Lion TCR Pte. Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lion TCR Pte. Ltd. | For profit | 2 | 2 | 1 | 2018 |
| Agency for Science, Technology and Research | Government | 1 | 0 | 1 | 2018 |
| Changhai Hospital | Academic/Hospital | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1